A recent study appearing in the online version of The Lancet warns of increased early failure rates for hip resurfacing implants. The study, conducted on behalf of the National Joint Registry for England and Wales, compared data from more 30,000 hip resurfacing procedures from April 2003 to September 2011.
On September 19, 2012, attorneys representing plaintiffs who have been injured by the Stryker Rejuvenate and ABG II modular hip implant devices filed a petition requesting the State of New Jersey to designate the litigation as “multi-county” litigation.
Health officials across the country are investigating an outbreak of fungal meningitis that has resulted in eight deaths. As of Monday, October 8th, there have been 105 reported cases in nine states.
The United States Judicial Panel on Multidistrict Litigation (JPML) issued an order on October 2, 2012 transferring eight product liability cases involving the Biomet M2a metal-on-metal hip replacement system for consolidated proceedings.
The U.S. Food and Drug Administration (FDA) has launched a website warning the public about the dangers of online pharmacies. The site also shows users how to determine if an online pharmacy is safe. For more information, visit www.FDA.gov/BeSafeRx